NVNO:NASDAQenVVeno Medical Corporation Analysis
Data as of 2026-06-11 - not real-time
$10.27
Latest Price
8/10Risk
Risk Level: High
Executive Summary
NVNO is trading well below its short‑term and long‑term moving averages, with a bearish MACD crossover and an RSI hovering in the neutral zone. The price sits near a technical support area and faces resistance just above the current level, while volume has been on a downward trend and 30‑day volatility remains extremely high. Fundamentally, the company reports negative earnings, a negative forward P/E, and a very low price‑to‑book ratio, indicating a distressed valuation despite a modest cash position and limited debt.
The recent FDA IDE approval for a pivotal non‑surgical venous valve study provides a potential catalyst that could shift sentiment, but the lack of revenue and operating cash outflows keep the risk profile elevated.
The recent FDA IDE approval for a pivotal non‑surgical venous valve study provides a potential catalyst that could shift sentiment, but the lack of revenue and operating cash outflows keep the risk profile elevated.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price below short‑term moving averages
- bearish MACD signal
- pending clinical data from FDA‑approved study
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- potential revenue lift if pivotal trial succeeds
- significant upside from low price‑to‑book valuation
- continued cash buffer despite operating losses
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- breakthrough medical‑device positioning in venous disease
- long‑term market opportunity if product gains regulatory clearance
- structural undervaluation relative to book value
Key Metrics & Analysis
Financial Health
P/E Ratio-8.6
ROE-60.65%
ROA-37.51%
Debt/Equity2.54
P/B Ratio0.3
Op. Cash Flow$-14788000
Free Cash Flow$-8367375
Industry P/E24.7
Technical Analysis
TrendBearish
RSI45.0
Support$9.04
Resistance$11.33
MA 20$10.54
MA 50$10.83
MA 200$16.16
MACDBearish
VolumeDecreasing
Fear & Greed Index84.2
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta2.04
Volatility62.49%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
1157
Zoomlion Heavy Industry Science and Technology Co., Ltd.
STOCK600835
Shanghai Mechanical & Electrical Industry Co., Ltd. Class A
STOCK002648
Satellite Chemical Co. Ltd. Class A
STOCK600426
Shandong Hualu-Hengsheng Chemical Co., Ltd. Class A
STOCK603501
OmniVision Integrated Circuits Group, Inc. Class A
STOCK600309
Wanhua Chemical Group Co. Ltd. Class A
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.